Bosutinib Attenuates Inflammation via Inhibiting Salt-Inducible Kinases in Experimental Model of Intracerebral Hemorrhage on Mice

Background and Purpose— Intracerebral hemorrhage (ICH) is a subtype of stroke with highest mortality and morbidity. Pronounced inflammation plays a significant role in the development of the secondary brain injury after ICH. Recently, SIK-2 (salt-inducible kinase-2) was identified as an important component controlling inflammatory response. Here we sought to investigate the role of SIK-2 in post-ICH inflammation and potential protective effects of SIK-2 inhibition after ICH. Methods— Two hundred and ninety-three male CD-1 mice were used. ICH was induced via injection of 30 &mgr;L of autologous blood. Recombinant SIK-2 was administrated 1 hour after ICH intracerebroventricularly. SIK-2 small interfering RNA was injected intracerebroventricularly 24 hours before ICH. Bosutinib, a clinically approved tyrosine kinase inhibitor with affinity to SIK-2, was given intranasally 1 hour or 6 hours after ICH. Effects of treatments were evaluated by neurological tests and brain water content calculation. Molecular pathways were investigated by Western blots and immunofluorescence studies. Results— Endogenous SIK-2 was expressed in microglia and neurons. SIK-2 expression was reduced after ICH. Exogenous SIK-2 aggravated post-ICH inflammation, leading to brain edema and the neurobehavioral deficits. SIK-2 inhibition attenuated post-ICH inflammation, reducing brain edema and ameliorating neurological dysfunctions. Bosutinib inhibited SIK-2–attenuating ICH-induced brain damage. Protective effects of Bosutinib were mediated, at least partly, by CRTC3 (cyclic amp-response element binding protein-regulated transcription coactivator 3)/cyclic amp-response element binding protein/NF-&kgr;B (nuclear factor-&kgr;B) pathway. Conclusions— SIK-2 participates in inflammation induction after ICH. SIK-2 inhibition via Bosutinib or small interfering RNA decreased inflammation, attenuating brain injury. SIK-2 effects are, at least partly, mediated by CRTC3-cyclic amp-response element binding protein-NF-&kgr;B signaling pathway.

[1]  A. Obenaus,et al.  Role of PDGF-D and PDGFR-β in neuroinflammation in experimental ICH mice model , 2016, Experimental Neurology.

[2]  A. Obenaus,et al.  Recombinant Osteopontin Stabilizes Smooth Muscle Cell Phenotype via Integrin Receptor/Integrin-Linked Kinase/Rac-1 Pathway After Subarachnoid Hemorrhage in Rats , 2016, Stroke.

[3]  A. K. Datusalia,et al.  NF-κB Inhibition Resolves Cognitive Deficits in Experimental Type 2 Diabetes Mellitus through CREB and Glutamate/GABA Neurotransmitters Pathway. , 2016, Current neurovascular research.

[4]  Lin Yuan,et al.  Resveratrol abrogates lipopolysaccharide-induced depressive-like behavior, neuroinflammatory response, and CREB/BDNF signaling in mice. , 2015, European journal of pharmacology.

[5]  Raymond Scott Turner,et al.  Nilotinib and bosutinib modulate pre-plaque alterations of blood immune markers and neuro-inflammation in Alzheimer’s disease models , 2015, Neuroscience.

[6]  Weiling Fu,et al.  Activation of Dopamine D2 Receptor Suppresses Neuroinflammation Through &agr;B-Crystalline by Inhibition of NF-&kgr;B Nuclear Translocation in Experimental ICH Mice Model , 2015, Stroke.

[7]  T. Ohkawara,et al.  Salt‐inducible kinase 3 deficiency exacerbates lipopolysaccharide‐induced endotoxin shock accompanied by increased levels of pro‐inflammatory molecules in mice , 2015, Immunology.

[8]  A. Gormand,et al.  SIK2 regulates CRTCs, HDAC4 and glucose uptake in adipocytes , 2015, Journal of Cell Science.

[9]  Yan Peng,et al.  17&bgr;-Estradiol Attenuates Hematoma Expansion Through Estrogen Receptor &agr;/Silent Information Regulator 1/Nuclear Factor-kappa B Pathway in Hyperglycemic Intracerebral Hemorrhage Mice , 2015, Stroke.

[10]  Daniel J. O'Connell,et al.  Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cells , 2014, Proceedings of the National Academy of Sciences.

[11]  E. Jung,et al.  Salt-inducible kinases 1 and 3 negatively regulate Toll-like receptor 4-mediated signal. , 2013, Molecular endocrinology.

[12]  J. Badaut,et al.  siRNA Treatment: “A Sword-in-the-Stone” for Acute Brain Injuries , 2013, Genes.

[13]  Beilei Lei,et al.  Tumor necrosis factor alpha antagonism improves neurological recovery in murine intracerebral hemorrhage , 2013, Journal of Neuroinflammation.

[14]  John H. Zhang,et al.  Hydrogen Inhalation Ameliorated Mast Cell–Mediated Brain Injury After Intracerebral Hemorrhage in Mice , 2013, Critical care medicine.

[15]  Patrick G. A. Pedrioli,et al.  PGE2 Induces Macrophage IL-10 Production and a Regulatory-like Phenotype via a Protein Kinase A–SIK–CRTC3 Pathway , 2013, The Journal of Immunology.

[16]  Patrick G. A. Pedrioli,et al.  Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages , 2012, Proceedings of the National Academy of Sciences.

[17]  R. Shaw,et al.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism , 2011, Nature Cell Biology.

[18]  John H. Zhang,et al.  Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury , 2011, Neurochemistry International.

[19]  S. Sakoda,et al.  SIK2 Is a Key Regulator for Neuronal Survival after Ischemia via TORC1-CREB , 2011, Neuron.

[20]  Qing-hui Zhou,et al.  Brain-Penetrating Tumor Necrosis Factor Decoy Receptor in the Mouse , 2011, Drug Metabolism and Disposition.

[21]  John H. Zhang,et al.  Heat shock protein 70 upregulation by geldanamycin reduces brain injury in a mouse model of intracerebral hemorrhage , 2010, Neurochemistry International.

[22]  K. Miyao,et al.  Tumor Necrosis Factor-α Mediates the Blood–Brain Barrier Dysfunction Induced by Activated Microglia in Mouse Brain Microvascular Endothelial Cells , 2010 .

[23]  K. Miyao,et al.  Tumor necrosis factor-alpha mediates the blood-brain barrier dysfunction induced by activated microglia in mouse brain microvascular endothelial cells. , 2010, Journal of pharmacological sciences.

[24]  J. Cortes,et al.  Kinase inhibitors in chronic myelogenous leukemia. , 2006, Clinical advances in hematology & oncology : H&O.

[25]  N. Horike,et al.  Salt-inducible kinase (SIK) isoforms: their involvement in steroidogenesis and adipogenesis , 2004, Molecular and Cellular Endocrinology.

[26]  M. Baudry,et al.  The Salt‐Inducible Kinase, SIK, Is Induced by Depolarization in Brain , 2000, Journal of neurochemistry.

[27]  M. Okamoto,et al.  Cloning of a novel kinase (SIK) of the SNF1/AMPK family from high salt diet‐treated rat adrenal1 , 1999, FEBS letters.